MedTrace Logo

Sleep Disturbance in Patients With End-Stage Renal Disease

NCT02583347 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2017-08-28

No results posted yet for this study

Summary

Sleep disorders are common in patients who have chronic kidney disease (CKD). Insomnia is reported in up to 50% of patients treated with hemodialysis compared to 12% of a control population. Restless leg syndrome (RLS) and periodic limb movement disorder (PLM) have been described in 30 to 70% of patients with end stage kidney disease (ESKD). Patients with CKD have also been reported to have a very high prevalence of sleep apnoea disorder. Conventional hemodialysis and peritoneal dialysis do not appear to improve sleep disorders in patients with CKD. There is emerging evidence that nocturnal HD can lead to improvements in sleep quality. Transplantation is thought to improve sleep-related disorders in some but not all patients.

Project Aims

The aims of this project were three-fold:

1. To perform detailed assessment of sleep quality in a cohort of Irish patients with ESRD
2. To assess the feasability and tolerability of unattended home PSG and wrist actigraphy as diagnostic tools in this cohort
3. To assess the impact of a change in RRT modality on sleep quality in Irish patients with ESRD

Conditions

  • Renal Failure Chronic Requiring Hemodialysis
  • Sleep Disorders

Interventions

DEVICE

Vivia Home Hemodialysis System

The cohort of interest is those patients performing nocturnal home hemodialysis using the Vivia Home Hemodialysis System for 8 hours, 5 nights per week

Sponsors & Collaborators

  • Baxter Healthcare Corporation

    collaborator INDUSTRY

  • Beaumont Hospital

    lead OTHER

Principal Investigators

  • Peter J Conlon, MB, MHS · Beaumont Hospital

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2018-07-31
Completion
2018-07-31

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02583347 on ClinicalTrials.gov